IP Library Granted Patent US 9,789,210
Granted Patent B1
US 9,789,210 · App. 15/461,469 · Granted Oct 17, 2017

Methods for making ultrasound contrast agents

Inventors: Simon P. Robinson (Stow, MA); Robert W. Siegler (Chelmsford, MA); Nhung Tuyet Nguyen (Westford, MA); David C. Onthank (Groton, MA); Tarakeshwar Vishwanath Anklekar (Billerica, MA); Charles Chester Van Kirk (Beverly, MA)
Assignee: Lantheus Medical Imaging, Inc.
A61K49/223A61K49/227A61K49/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,789,210
App. No.
15/461,469
Granted
Oct 17, 2017
Kind
B1
Abstract

Provided herein are improved methods for preparing phospholipid formulations including phospholipid UCA formulations.

Claims (15)

1. A method of ultrasound contrast imaging a subject comprising

(a) activating a phospholipid suspension with a perfluorocarbon gas to form lipid-encapsulated gas microspheres, wherein the phospholipid suspension comprises a phospholipid solution having DPPA, DPPC and MPEG5000-DPPE, in a mole % ratio of 10 to 82 to 8 (10:82:8), in propylene glycol, the MPEG5000-DPPE selected as having a calcium concentration of less than 115 parts per million (ppm), and the phospholipid solution having a calcium concentration of less than 0.7 ppm,

(b) administering the lipid-encapsulated gas microspheres to a subject, and

(c) obtaining an ultrasound image of the subject.

2. A method of ultrasound contrast imaging a subject comprising

(a) activating a phospholipid suspension with a perfluorocarbon gas to form lipid-encapsulated gas microspheres, wherein the phospholipid suspension comprises a phospholipid solution made under a methanol and toluene free condition and a methyl t-butyl ether free condition and having DPPA, DPPC and MPEG5000-DPPE, in a mole % ratio of 10 to 82 to 8 (10:82:8), in propylene glycol, the MPEG5000-DPPE having a calcium concentration of less than 115 parts per million (ppm), and the phospholipid solution having a calcium concentration of less than 0.7 ppm,

(b) administering the lipid-encapsulated gas microspheres to a subject, and

(c) obtaining an ultrasound image of the subject.

3. The method of claim 2 , wherein the calcium concentration is determined using atomic absorption spectroscopy.

4. The method of claim 1 , wherein the calcium concentration is determined using atomic absorption spectroscopy.

5. The method of claim 1 , wherein the calcium concentration is determined using inductively coupled plasma mass spectrometry (ICP-MS).

6. The method of claim 2 , wherein the calcium concentration is determined using inductively coupled plasma-mass spectrometry (ICP-MS).

7. The method of claim 1 , wherein the calcium concentration of DPPA is less than 780 ppm, the calcium concentration of DPPC is less than 90 ppm, and the calcium concentration of propylene glycol is less than 0.7 ppm.

8. The method of claim 2 , wherein the calcium concentration of DPPA is less than 780 ppm, the calcium concentration of DPPC is less than 90 ppm, and the calcium concentration of propylene glycol is less than 0.7 ppm.

9. The method of claim 2 , wherein MPEG5000-DPPE is selected as having a calcium concentration of less than 115 ppm.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Dec 2, 2022
From: WELLS FARGO BANK, N.A.
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 062047/0925 →
SECURITY INTEREST Recorded Dec 2, 2022
From: LANTHEUS MEDICAL IMAGING, INC.; MOLECULAR INSIGHT PHARMACEUTICALS, INC.; PSMA DEVELOPMENT COMPANY, LLC; PROGENICS PHARMACEUTICALS, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 062047/0960 →
SECURITY AGREEMENT Recorded Jun 28, 2019
From: LANTHEUS MEDICAL IMAGING, INC.
To: WELLS FARGO BANK, N.A.
Reel/Frame 049628/0001 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2019
From: JPMORGAN CHASE BANK, N.A.
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 049623/0123 →
PATENT SECURITY AGREEMENT Recorded Apr 12, 2018
From: LANTHEUS MEDICAL IMAGING, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 045929/0908 →
CONFIRMATORY ASSIGNMENT Recorded Mar 2, 2018
From: ROBINSON, SIMON P.; SIEGLER, ROBERT W.; NGUYEN, NHUNG TUYET; ONTHANK, DAVID C.; VAN KIRK, CHARLES CHESTER; ANKLEKAR, TARAKESHWAR VISHWANATH
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 045484/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2017
From: ROBINSON, SIMON P.; SIEGLER, ROBERT W.; NGUYEN, NHUNG TUYET; ONTHANK, DAVID C.; ANKLEKAR, TARAKESHWAR VISHWANATH; VAN KIRK, CHARLES CHESTER
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 043491/0311 →
Continuity (1)
Provisional Application 62359181 · Jul 6, 2016